These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 23123301)
21. Human osteoblasts exhibit sexual dimorphism in their response to estrogen on microstructured titanium surfaces. Berger MB; Cohen DJ; Olivares-Navarrete R; Williams JK; Cochran DL; Boyan BD; Schwartz Z Biol Sex Differ; 2018 Jul; 9(1):30. PubMed ID: 29970177 [TBL] [Abstract][Full Text] [Related]
22. Regulating the osteogenic function of rhBMP 2 by different titanium surface properties. Xiao M; Biao M; Chen Y; Xie M; Yang B J Biomed Mater Res A; 2016 Aug; 104(8):1882-93. PubMed ID: 26991341 [TBL] [Abstract][Full Text] [Related]
23. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin. Kodama T; Goto T; Miyazaki T; Takahashi T Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269 [TBL] [Abstract][Full Text] [Related]
25. Immobilization of BMP-2, BMP-7 and alendronic acid on titanium surfaces: Adhesion, proliferation and differentiation of bone marrow-derived stem cells. Kämmerer PW; Pabst AM; Dau M; Staedt H; Al-Nawas B; Heller M J Biomed Mater Res A; 2020 Feb; 108(2):212-220. PubMed ID: 31587476 [TBL] [Abstract][Full Text] [Related]
26. Regulation of mesenchymal stem cell differentiation on microstructured titanium surfaces by semaphorin 3A. Lotz EM; Berger MB; Boyan BD; Schwartz Z Bone; 2020 May; 134():115260. PubMed ID: 32028017 [TBL] [Abstract][Full Text] [Related]
28. Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography. Zhao G; Raines AL; Wieland M; Schwartz Z; Boyan BD Biomaterials; 2007 Jun; 28(18):2821-9. PubMed ID: 17368532 [TBL] [Abstract][Full Text] [Related]
29. Gentamicin and bone morphogenic protein-2 (BMP-2)-delivering heparinized-titanium implant with enhanced antibacterial activity and osteointegration. Lee DW; Yun YP; Park K; Kim SE Bone; 2012 Apr; 50(4):974-82. PubMed ID: 22289658 [TBL] [Abstract][Full Text] [Related]
30. Strontium attenuates rhBMP-2-induced osteogenic differentiation via formation of Sr-rhBMP-2 complex and suppression of Smad-dependent signaling pathway. Zhang W; Tian Y; He H; Chen R; Ma Y; Guo H; Yuan Y; Liu C Acta Biomater; 2016 Mar; 33():290-300. PubMed ID: 26828127 [TBL] [Abstract][Full Text] [Related]
31. Bone formation around zirconia implants combined with rhBMP-2 gel in the canine mandible. Lee BC; Yeo IS; Kim DJ; Lee JB; Kim SH; Han JS Clin Oral Implants Res; 2013 Dec; 24(12):1332-8. PubMed ID: 22934611 [TBL] [Abstract][Full Text] [Related]
32. Local factor production by MG63 osteoblast-like cells in response to surface roughness and 1,25-(OH)2D3 is mediated via protein kinase C- and protein kinase A-dependent pathways. Schwartz Z; Lohmann CH; Sisk M; Cochran DL; Sylvia VL; Simpson J; Dean DD; Boyan BD Biomaterials; 2001 Apr; 22(7):731-41. PubMed ID: 11246968 [TBL] [Abstract][Full Text] [Related]
33. Semaphorin 3A delivered by a rapidly polymerizing click hydrogel overcomes impaired implant osseointegration in a rat type 2 diabetes model. Deng J; Cohen DJ; Sabalewski EL; Van Duyn C; Wilson DS; Schwartz Z; Boyan BD Acta Biomater; 2023 Feb; 157():236-251. PubMed ID: 36435442 [TBL] [Abstract][Full Text] [Related]
34. Increased osseointegration effect of bone morphogenetic protein 2 on dental implants: an in vivo study. Yoo D; Tovar N; Jimbo R; Marin C; Anchieta RB; Machado LS; Montclare J; Guastaldi FP; Janal MN; Coelho PG J Biomed Mater Res A; 2014 Jun; 102(6):1921-7. PubMed ID: 23853058 [TBL] [Abstract][Full Text] [Related]
35. Bone formation at porous titanium implants coated with multiple layers of recombinant human bone morphogenetic protein-2 cDNA plasmid in the posterior mandible in dogs. He FM; Shan HQ; Shen JW; Jiang QH Int J Oral Maxillofac Implants; 2013; 28(6):1648-54. PubMed ID: 24278934 [TBL] [Abstract][Full Text] [Related]
36. Effect of recombinant human bone morphogenetic protein-7 (rhBMP-7) on the viability, proliferation and differentiation of osteoblast-like cells cultured on a chemically modified titanium surface. Togashi AY; Cirano FR; Marques MM; Pustiglioni FE; Lang NP; Lima LA Clin Oral Implants Res; 2009 May; 20(5):452-7. PubMed ID: 19250243 [TBL] [Abstract][Full Text] [Related]
37. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates. Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396 [TBL] [Abstract][Full Text] [Related]
38. The effect of combined delivery of recombinant human bone morphogenetic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate-coated implants on osseointegration. Ramazanoglu M; Lutz R; Ergun C; von Wilmowsky C; Nkenke E; Schlegel KA Clin Oral Implants Res; 2011 Dec; 22(12):1433-9. PubMed ID: 21418332 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of cyclooxygenase by indomethacin modulates osteoblast response to titanium surface roughness in a time-dependent manner. Sisk MA; Lohmann CH; Cochran DL; Sylvia VL; Simpson JP; Dean DD; Boyan BD; Schwartz Z Clin Oral Implants Res; 2001 Feb; 12(1):52-61. PubMed ID: 11168271 [TBL] [Abstract][Full Text] [Related]
40. Improved osseointegration of dental titanium implants by TiO2 nanotube arrays with recombinant human bone morphogenetic protein-2: a pilot in vivo study. Lee JK; Choi DS; Jang I; Choi WY Int J Nanomedicine; 2015; 10():1145-54. PubMed ID: 25709438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]